PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0006287|bronchopulmonary dysplasia |
| Sentences | 9 |
| PubMedID- 22311993 | Objectives: pulmonary hypertension is associated with bronchopulmonary dysplasia in extremely low birth weight (elbw) infants and contributes to morbidity and mortality. |
| PubMedID- 22848815 | More recently pulmonary hypertension (ph) associated with bronchopulmonary dysplasia (bpd) has been identified as a significant cause of mortality among bpd patients [1, 2]. |
| PubMedID- 23788443 | pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes. |
| PubMedID- 21189939 | pulmonary hypertension in infants with bronchopulmonary dysplasia. |
| PubMedID- 24616323 | pulmonary hypertension in bronchopulmonary dysplasia. |
| PubMedID- 26432873 | Supplemental oxygen after premature birth results in aberrant airway, alveolar, and pulmonary vascular development with an increased risk for bronchopulmonary dysplasia, and development of wheeze and asthma, pulmonary hypertension, and chronic obstructive pulmonary disease in survivors. |
| PubMedID- 24866752 | Sildenafil, a phospohodiesterase-5 inhibitor, is widely used to treat pulmonary hypertension in infants with bronchopulmonary dysplasia despite a lack of evidence to support either safety or efficacy and us fda advice against its use. |
| PubMedID- 23582967 | pulmonary hypertension in bronchopulmonary dysplasia. |
| PubMedID- 25231322 | Echocardiographic assessment of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review of literature and a proposed algorithm for assessment. |
Page: 1